Psychological Science:服用避孕药改变你的理想型?调查发现并非如此

2018-05-11 佚名 DeepTech深科技

本周《心理科学》(Psychological Science)上的一篇新论文表示,以往关于男性是如何吸引女性的普遍理论可能错了。此前,一些小型的实验发现避孕药和排卵可以改变女性的性偏好。现在,一项大型的新研究发现,不管女性是否服用避孕药或正在排卵,她们对男性面孔的偏好还是相当稳定的。

一项新的研究发现,异性恋女性倾向于青睐更为传统的阳刚的男性面孔,并且这种偏好与她们是否口服避孕药无关。

本周《心理科学》(Psychological Science)上的一篇新论文表示,以往关于男性是如何吸引女性的普遍理论可能错了。此前,一些小型的实验发现避孕药和排卵可以改变女性的性偏好。现在,一项大型的新研究发现,不管女性是否服用避孕药或正在排卵,她们对男性面孔的偏好还是相当稳定的。

以往的一些实验发现,服用激素类避孕药或正处于月经周期的女性更青睐阴柔一些的男性面部特征,比如更圆的下巴或更细的眉毛。但是英国格拉斯哥大学神经科学和心理学研究所(Institute of Neuroscience and Psychology)的教授本·琼斯(Ben Jones)兼该研究的主要作者表示,这些研究可能从一开始就存在缺陷。


“研究人员已经强调了这些研究在方法上可能出现的问题,比方说参加测试的女性数量相对较少的问题,”他表示,“针对这些评论,我们开展了至今为止最大规模的研究。”

琼斯和他的团队在英国招募了超过 500 名异性恋女性来参与他们的研究。被试面前会同时呈现 10 对经过挑选了的男性面孔,她们需要选出她们认为最吸引人的一张面孔,并对该面孔的吸引力进行评估。这些男性面孔都有经过略微的修饰,变得更阳刚或更阴柔一些;也就是说,男性颧骨的突出程度很有可能发生变化。在每个试验阶段(testing session)中,被试都会分为两组,一组从发展短期关系角度,另一组则从发展长期关系(婚姻关系)角度,对这些面孔进行评估。

被试最初需要参加长达五周的测试,在这五周内每周都要参加测试;五周后第一轮测试结束,六个月后再来参加第二轮测试,再然后是大约两年后的更多轮的测试。在每个试验阶段中,被试还需提交唾液样本,以追踪其激素水平。尽管六个月后参加第二轮测试的被试只有 6 名,两年后参加第三轮测试的也只有 3 名,但好歹大多数被试完成了时长五周的第一轮测试。

琼斯表示:“我们并没有发现有证据表明,女性对男性面孔的偏好会随着激素水平或女性使用口服避孕药的改变而发生变化。相反,我们发现不管女性自身激素水平如何,她们普遍还是青睐更加阳刚的男性。”

然而,这项研究有其局限性。一方面,所有被试都是白人,并且所有经过修饰的图片中的男性也都是白人。当然,这项实验高度可控,图片中的男性面孔都是经过实验室修饰的。可是从研究的适用性角度看,这些经过修饰的图片是否能与在现实中挑选的真正男性的图片相比,则有待讨论了。

尽管琼斯指出,这仅仅是一项研究。在此之后,今年 3 月份又有一篇论文报告了类似的发现。该论文发现,女性被试其月经周期并不影响她们对男性身体整体的吸引力。

琼斯表示:“在我看来,未来该领域研究的关键需要研究者扩大研究的规模和范围,并且不要害怕返回和测试已被认可的结果。同时,令人振奋的是,科学期刊越来越愿意发表这类没什么价值的研究结果,而不仅仅是那些证实我们所知事情的研究结果了。”

然而,与其他研究类似,他们发现,在选择发展短期关系方面,女性被试通常会选择那些更加阳刚的面孔;然而在发展长期关系方面,女性则普遍选择面孔相对没那么阳刚的男性。

最后,琼斯和他的团队希望,他们的发现能够缓解那些采取避孕措施的女性对药效的担忧。

琼斯表示:“在考虑要不要使用激素类避孕药方面,女性会考虑诸多因素。根据我们的研究结果,这些药物对吸引力并不会产生极大的影响,所以在做这类决定时请不要将其可能产生的效应看得太重。”

原始出处:

Benedict C. Jones, Amanda C. Hahn, Claire I. Fisher, et al. No Compelling Evidence That Preferences for Facial Masculinity Track Changes in Women’s Hormonal Status. Psychological Science, 2018.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1792851, encodeId=a3f91e928512e, content=<a href='/topic/show?id=6c331481977' target=_blank style='color:#2F92EE;'>#Psychologic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14819, encryptionId=6c331481977, topicName=Psychologic)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fb6449, createdName=ZGMFX24A, createdTime=Fri Feb 15 12:38:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375820, encodeId=29ae13e5820ff, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Sun May 13 02:38:00 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314157, encodeId=915231415e72, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri May 11 13:38:17 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314144, encodeId=fd753141446b, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Fri May 11 13:12:20 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314133, encodeId=dc853141336a, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri May 11 12:46:56 CST 2018, time=2018-05-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1792851, encodeId=a3f91e928512e, content=<a href='/topic/show?id=6c331481977' target=_blank style='color:#2F92EE;'>#Psychologic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14819, encryptionId=6c331481977, topicName=Psychologic)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fb6449, createdName=ZGMFX24A, createdTime=Fri Feb 15 12:38:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375820, encodeId=29ae13e5820ff, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Sun May 13 02:38:00 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314157, encodeId=915231415e72, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri May 11 13:38:17 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314144, encodeId=fd753141446b, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Fri May 11 13:12:20 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314133, encodeId=dc853141336a, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri May 11 12:46:56 CST 2018, time=2018-05-11, status=1, ipAttribution=)]
    2018-05-13 jichang
  3. [GetPortalCommentsPageByObjectIdResponse(id=1792851, encodeId=a3f91e928512e, content=<a href='/topic/show?id=6c331481977' target=_blank style='color:#2F92EE;'>#Psychologic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14819, encryptionId=6c331481977, topicName=Psychologic)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fb6449, createdName=ZGMFX24A, createdTime=Fri Feb 15 12:38:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375820, encodeId=29ae13e5820ff, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Sun May 13 02:38:00 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314157, encodeId=915231415e72, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri May 11 13:38:17 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314144, encodeId=fd753141446b, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Fri May 11 13:12:20 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314133, encodeId=dc853141336a, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri May 11 12:46:56 CST 2018, time=2018-05-11, status=1, ipAttribution=)]
    2018-05-11 1ddf0692m34(暂无匿称)

    学习了.谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1792851, encodeId=a3f91e928512e, content=<a href='/topic/show?id=6c331481977' target=_blank style='color:#2F92EE;'>#Psychologic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14819, encryptionId=6c331481977, topicName=Psychologic)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fb6449, createdName=ZGMFX24A, createdTime=Fri Feb 15 12:38:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375820, encodeId=29ae13e5820ff, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Sun May 13 02:38:00 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314157, encodeId=915231415e72, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri May 11 13:38:17 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314144, encodeId=fd753141446b, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Fri May 11 13:12:20 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314133, encodeId=dc853141336a, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri May 11 12:46:56 CST 2018, time=2018-05-11, status=1, ipAttribution=)]
    2018-05-11 神功盖世

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1792851, encodeId=a3f91e928512e, content=<a href='/topic/show?id=6c331481977' target=_blank style='color:#2F92EE;'>#Psychologic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14819, encryptionId=6c331481977, topicName=Psychologic)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fb6449, createdName=ZGMFX24A, createdTime=Fri Feb 15 12:38:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375820, encodeId=29ae13e5820ff, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Sun May 13 02:38:00 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314157, encodeId=915231415e72, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri May 11 13:38:17 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314144, encodeId=fd753141446b, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Fri May 11 13:12:20 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314133, encodeId=dc853141336a, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri May 11 12:46:56 CST 2018, time=2018-05-11, status=1, ipAttribution=)]
    2018-05-11 惠映实验室

    学习了.谢谢分享.

    0

相关资讯

Ann Rheum Dis:多学科讨论:口服避孕药和母乳喂养是否降低类风湿性关节炎风险?

类风湿性关节炎(RA)是最常见的自身免疫性疾病之一,病因学的遗传和环境因素的相互作用复杂。2017年11月,发表在《Ann Rheum Dis》的瑞典EIRA研究结果,考察了口服避孕药(OC)、母乳喂养(BF)与RA风险之间的相关性。请看本期多学科讨论组临床药师各抒己见为您梳理本文看点——

喜大普奔:安全有效的男性避孕药即将问世

2013 年,莫纳什大学的科学家进行了一项研究。结果证明,在老鼠身上,α1A- 肾上腺受体和 P2X1- 嘌呤受体可被安全剔除,从而实现 100% 不育,同时不影响性行为或性功能。

避孕药和激素替代疗法究竟会不会引起乳腺癌?

避孕药和激素替代疗法会不会引起乳腺癌?关于这个问题,需要从乳腺癌的病因出发进行分析。我们已经知道,乳腺是受性激素作用的器官,它随体内激素含量的变化而变化。雌激素参与乳腺增值,若长期暴露于雌激素下则会促使乳腺癌的发病。而孕激素对乳腺的作用则褒贬不一,部分学者认为它对乳腺具有保护作用,也有部分人认为它同样参与乳腺增值过程,同样可促进乳腺癌的发病。避孕药与乳腺癌避孕药的成分多为孕雌激素复方制剂,但其中两

NEJM:研究表明所有激素类避孕药都会极大增加患癌风险!

新的研究增加了越来越多的证据表明服用激素避孕药会增加患乳腺癌的相对风险。

Stroke:注意|这几件事可能增加会脑梗风险

近日,《卒中》杂志发表了以具体教学案例为例,探讨口服避孕药与缺血性卒中风险的相关性,并总结了教学时需牢记的几点问题。

JAMA Oncol:避孕药可大大降低女性癌症发病率!

避孕药的使用可以降低卵巢癌的发生率。而在近期,一项超10万人的研究不仅坐实了这个结论,并且研究结果十分喜人:哪怕是吸烟和肥胖患者,服用避孕药依旧可以降低卵巢癌的发生率!